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Abstract
Background: Marrow mesenchymal stem cells (MSCs) can differentiate into specific phenotypes, including chondrocytes,
and have been widely used for cartilage tissue engineering. However, cartilage grafts from MSCs exhibit phenotypic
alternations after implantation, including matrix calcification and vascular ingrowth.
Methods: We compared chondromodulin-1 (Chm-1) expression between chondrocytes and MSCs. We found that
chondrocytes expressed a high level of Chm-1. We then adenovirally transduced MSCs with Chm-1 and applied
modified cells to engineer cartilage in vivo.
Results: A gross inspection and histological observation indicated that the chondrogenic phenotype of the
tissue-engineered cartilage graft was well maintained, and the stable expression of Chm-1 was detected by
immunohistological staining in the cartilage graft derived from the Chm-1 gene-modified MSCs.
Conclusions: Our findings defined an essential role for Chm-1 in maintaining chondrogenic phenotype and
demonstrated that Chm-1 gene-modified MSCs may be used in cartilage tissue engineering.
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Background
Cartilage regeneration and repair is often needed in
orthopedic or plastic and reconstructive surgery for the
treatment of cartilaginous defects and malformations.
Unlike other self-repairing tissues, cartilage is an avascu-
lar tissue characterized by a low cell density and limited
nutrient supply [1, 2]. Because of the limited regenera-
tive capacity of cartilage, the treatment of various cartil-
aginous lesions remains a challenge to clinicians.
Tissue engineering provides an optimized alternative
for cartilage regeneration and repair by combining chon-
drogenic cells and a scaffold [3, 4]. Chondrocytes are
most commonly used for cartilage tissue engineering.
However, the harvesting of a cartilage biopsy to obtain
primary chondrocytes may cause donor site morbidity,
and chondrocytes will dedifferentiate and lose their
chondrogenic phenotype during monolayer expansion
[5]. Compared with chondrocytes, marrow mesenchymal
stem cells (MSCs) could be easily isolated, expanded,
and directed to differentiate into mesodermal lineages,
including bone, cartilage, and adipose tissue [6, 7]. MSCs
may undergo chondrogenic differentiation with the
induction of transforming growth factor beta (TGF-β),
especially under micropellet culture condition [8], and
great efforts have been made to use MSCs for cartilage
tissue engineering [9–11]. However, cartilage grafts from
MSCs undergo gradual histological changes after
implantation, including chondrocyte hypertrophy, extra-
cellular matrix calcification, and vascular invasion, which
may significantly influence the treatment outcome of
cartilage defects [12, 13].
Coculturing with chondrocytes was usually employed
to maintain the stable chondrogenic phenotype of MSCs.
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The approach could improve collagen type II and gly-
cosaminoglycan expression as well as the deposition of
MSCs. The mechanism was attributed to signaling via
direct cell–cell contacts [14–16] and paracrine factors
secreted by chondrocytes [17, 18]. Kang et al. [19]
demonstrated that a 1:1 ratio of chondrocytes to MSCs
can be used to engineer phenotypically stable cartilage,
and obvious vascular invasion could not be observed
6 weeks after in-vivo implantation. However, engineering
cartilage with co-seeding of chondrocytes and MSCs still
requires the surgical harvesting of cartilage biopsy to
obtain chondrocytes [20].
Chondromodulin-1 (Chm-1) is a glycoprotein with
25 kDa molecular weight and is found highly expressed
in cartilage tissue [21]. Chm-1 could inhibit the endothe-
lial cell proliferation and tube morphogenesis, induce
apoptisis of vascular endothelial cells in vitro, as well as
inhibit angiogenesis in the chick chorioallantoic mem-
brane [22–24]. Mature cartilage contains considerable
amounts of Chm-1, is avascular, and its extracellular
matrix does not calcify. Meanwhile healing cartilage
from MSCs within the cartilage lesions of the knee joint
lacked Chm-1 expression, and exhibited excessive ossifi-
cation and vascularization [25]. Based on these findings,
we may deduce that the phenotypic drift of cartilage
grafts from MSCs after in-vivo implantation is due to
the low expression of Chm-1 in MSCs.
In the current experiment, we first compared Chm-1
expression profiles in MSCs and chondrocytes. We then
engineered phenotypically stable cartilage grafts from
Chm-1 gene-modified MSCs. Coral has an interconnec-
tive porous structure and good osteoconductive activity
which are suitable for blood vessel invasion and tissue
ossification [26–28]. We chose coral as the cell-seeding
scaffold to investigate the critical effect of Chm-1 on
antivascularization and maintaining the chondrogenic
phenotype of tissue-engineered cartilage with MSCs.
Methods
All reagents were purchased from Sigma-Aldrich (St.
Louis, MO, USA) unless otherwise specified.
Isolation and culture of MSCs and chondrocytes
Rabbit MSCs were isolated and cultured as reported
previously [28]. New Zealand rabbits (1 month old) were
obtained from the animal holding unit of Four Military
Medical University (FMMU, Xi'an, Shaanxi Province, P.R.
China) and samples of bone marrow were harvested in ac-
cordance with IACUC approval from Northwest Univer-
sity, Xi’an, P.R. China. Briefly, the obtained marrow was
suspended and cultured in Dulbecco’s modified Eagle
medium (DMEM; Gibco BRL, Grand Island, NY, USA)
containing 10 % fetal bovine serum (FBS), 272 μg/ml L-
glutamine, and 100 U/ml penicillin/streptomycin. The
media were changed every 3 days. Before the cells formed
a confluent monolayer, they were digested using trypsin
0.25 % and harvested by centrifugation, and cells of pas-
sage 2 were used for the experiment. The cell density was
adjusted to 5 × 107 cells/ml with medium before cell
seeding.
Rabbit chondrocytes were isolated and cultured ac-
cording to the method described by Wu et al. [29]. All
New Zealand rabbits were anesthetized with ketamine
(40 mg/kg, intramuscularly) and xylazine (5 mg/kg,
intramuscularly). After aseptic preparation, the auricle
cartilage from ear roots was dissected and cut into
pieces of approximately 2 mm3 after being rinsed three
times with phosphate-buffered saline (PBS) supple-
mented with 100 U/ml penicillin and 100 U/ml strepto-
mycin; the cartilage samples were digested with 0.2 %
collagenase type II (Gibco) in DMEM (Gibco) at 37 °C
for 12 hours. The digested cell suspension was filtered
through a 250 mm nylon mesh filter to remove matrix
debris and was centrifuged at 1000 rpm for 5 minutes; the
resulting cell pellet was washed twice with PBS and resus-
pended with DMEM containing 10 % FBS, L-glutamine
(272 μg/ml), and ascorbic acid (5 μg/ml). The medium
was changed every 3 days. The chondrocytes were subcul-
tured twice, collected by trypsin digestion, and suspended
in culture medium at a density of 5 × 107 cells/ml for
seeding.
RNA isolation and reverse transcription-PCR
The expression levels of Chm-1, Col II, and AGG in
chondrocytes and MSCs were compared by reverse
transcription-PCR (RT-PCR). Total RNA was isolated
from chondrocytes and MSCs using TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA). For cDNA synthesis,
RT-PCR was performed using the Takara RT-PCR Kit
(Takara, Dalian, China). The reaction product cDNA
was used as a template for PCR amplification. The PCR
conditions were as follows: initial denaturation at 94 °C
for 3 minutes; 30 cycles at 94 °C for 40 seconds, 60 °C
for 40 seconds, and 72 °C for 80 seconds; and a final ex-
tension at 72 °C for 5 minutes. The PCR products were
visualized on 1.5 % agarose gels. GAPDH was used as an
internal control. The primer sequences used for this
analysis are presented in Table 1. Band intensity was
quantified using Bandscan software. The gray values of
bands were normalized relative to those of GAPDH. The
gray values were expressed in relation to the control and
presented as means ± SD from four independent
experiments.
Western blot analysis
Western blot analysis was carried out for Chm-1, Col II,
and AGG expression of MSCs and chondrocytes. Equal
amounts of protein extracts (30 μg/lane) were separated
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by SDS-PAGE and transferred to the nitrocellulose
membrane. Nonspecific binding was blocked with TBS
buffer (50 mM Tris/HCl and 150 mM NaCl) containing
5 % (w/v) skimmed milk for 2 hours at room tem-
perature. The membranes were then incubated with pri-
mary antibodies (1:1000 (v/v) for GAPDH, 1:1000 (v/v)
for Chm-1, 1:1000 (v/v) for Col II, and 1:1000 (v/v) for
AGG; Santa Cruz, Santa Cruz, California, USA) for
2 hours at 37 °C. After washing with TBS containing
0.05 % Tween-20 (TBST) three times, the membranes
were incubated for 1 hour at 37 °C with secondary anti-
bodies conjugated with horseradish peroxidase diluted
1:1000 in TBST. Finally, the membranes were treated
with enhanced chemoluminescence (ECL) reagent (Santa
Cruz) and exposed to Kodak X-ray film. GAPDH acted
as internal control.
MSCs modified with Chm-1 gene
Chm-1 cDNAs were amplified from rabbit chondrocytes
by PCR using the primers presented in Table 1. The
PCR products were subcloned into the pDC316 expres-
sion adenovirus vector (pDC316-Chm-1) after restriction
enzyme digestion. According to the manufacturer’s in-
structions for the AdMax Kit D (Microbix Biosystems
Inc.,Toronto, ON, Canada), HEK 293 producer cells
were cotransfected with pBHGlox E1, 3Cre, and expres-
sion adenovirus vector (pDC316-Chm-1) to obtain the
adenovirus-containing Chm-1 gene (Ad5-Chm-1).
Second-passage rabbit MSCs were transduced with an
adenovirus containing either green fluorescent protein
(GFP) (Ad5-GFP) or Chm-1 (Ad5-Chm-1) for 72 hours
at a multiplicity of infection (MOI) of 1000 plaque-
forming units (PFU)/cell. The efficiency of adenovirus
gene transfer in MSCs was evaluated under a fluores-
cence microscope 72 hours after transfection.
Expression of Chm-1 in Ad5-Chm-1-transfected MSCs
Total RNA was isolated from MSCs before infection and
72 hours after infection using TRIzol Reagent (Invitrogen).
For cDNA synthesis, the total RNA was reverse-
transcribed using the Takara RT-PCR Kit for RT-PCR.
The reaction product cDNA was used as a template for
PCR amplification. The PCR conditions were as follows:
initial denaturation at 94 °C for 3 minutes; 30 cycles at
94 °C for 40 seconds, 60 °C for 40 seconds, and 72 °C for
80 seconds; and a final extension at 72 °C for 5 minutes.
PCR products were visualized on 1.5 % agarose gels.
GAPDH was used as the internal control. The primer se-
quences used for this analysis are presented in Table 1.
The gray values of bands were normalized relative to
those of GAPDH. The gray values were expressed in rela-
tion to the control and presented as means ± SD from four
independent experiments. To confirm the bioactivity of
transgenic Chm-1, the expression levels of Chm-1, Col II,
and AGG in Ad5-Chm-1-transfected MSCs (T-MSCs)
were measured by western blot analysis. The western blot
analysis was carried out as described previously. Further-
more, the Chm-1 and Col II proteins were detected by im-
munofluorescence. Briefly, the MSCs, chondrocytes, and
T-MSCs were washed three times with PBS (pH 7.4). Cells
were fixed for 10 minutes by incubating in 4 % formalde-
hyde in PBS followed by further washing and prein-
cubation with 1 % bovine serum albumin (BSA) for
30 minutes. Incubation was with anti-Chm-1 antibody
(Santa Cruz) and anti-Col II antibody (Santa Cruz) for
20 minutes at room temperature. Next, the samples were
rinsed in PBS followed by incubation with Cy3-conjugated
antimouse secondary antibody (Calbiochem, Darmstadt,
Germany) for 20 minutes at room temperature, PBS wash-
ing, and finally staining with 5 mg/ml Hoechst 33342 for
30 minutes. The fluorescence images from stained samples
were obtained using a confocal laser scanning microscope
(FV1000; Olympus Corporation, Tokyo, Japan).
Construction of cell–scaffold complex
Natural coral (Gonophoresduofaciata, Hainan, China)
was carefully molded into the shape of a tube that was
8 mm in diameter and 2 mm thick. The material was
treated as described previously [30]. Briefly, it was
immersed in 50 mg/ml sodium hypochlorite for 14 days,
and the medium was changed every other day to remove
foreign protein in the coral. The scaffold was then
washed with distilled water and autoclaved before use.
In preparation for cell seeding, empty scaffolds were
prewetted in culture medium for 10 minutes. Cells were
then pipetted onto each scaffold to achieve a final
seeding number of 2 × 106 cells in 40 μl suspensions.
Each scaffold was seeded with cells which were
Table 1 Primer sequences for reverse transcription-PCR
Gene Primers Product size (base pairs)
GAPDH TCACCATCTTCCAGGAGCGA 293
AGG CACAATGCCGAAGTGGTCGT GGTCGTGGTGAAAGGTGTTGT 315
Col II GCAGACGCATGAAGGCAAGTT AGCAGCAGCACGTGTGGTT 97
Chm-1 ATCTGGACGTTGGCAGTGTTG CCGCTCGAGCATGACCGAGAACTCGGACA 1022
CCGGAATTCGCACCTGATACGCAAAGTGA
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i) chondrocytes, ii) 1:1 mixture of MSCs and chondro-
cytes, iii) MSCs, and iv) T-MSCs. The cell–scaffold com-
plexes were placed into dishes and moved to the
incubator for 4 hours to ensure that most cells adhered
to the scaffolds. Then, 2 ml of medium was carefully
added around the complexes. Twelve hours later, an
additional 10 ml of medium was added. The composites
were then incubated for 5 days to allow for cell attach-
ment. Prior to implantation, the scaffolds were rinsed in
sterile PBS, stained with Hoechst 33342, and observed
through a fluorescence microscope (Nikon, Tokyo,
Japan). Twelve hours and 5 days after cell seeding, a
PicoGreen DNA quantitation assay [31] was used to
monitor cell-seeding efficacy and proliferation on coral
scaffolds (n = 4). The DNA quantitation of 2 × 106 cells
before seeding acted as controls.
Subcutaneous implantation in nude mice
Eight BALB/c nude mice (6 weeks old, from the animal
holding unit of FMMU) were used for the experiment.
The animals were acclimated for 1 week before the sur-
gery and monitored for general appearance, activity, ex-
cretion, and weight. All procedures were approved by
the IACUC of Northwest University. Before implant-
ation, the nude mice were anesthetized by intraperito-
neal injection of 10 % chloral hydrate (300 mg/kg). After
aseptic preparation, the skin on the back was incised
and a subcutaneous pocket was made. The coral–im-
plant composite scaffolds loaded with cells (four kinds of
composites: scaffold loaded with i) chondrocytes, ii) 1:1
chondrocytes and MSCs, iii) MSCs, and iv) T-MSCs)
were implanted into eight animals (each animal received
four kinds of implant). After 1 and 2 months of implant-
ation, the animals (n = 4, at each time point) were sacri-
ficed by neck dislocation and specimens were harvested.
The specimens were observed by gross inspection and
then fixed with 10 % phosphate-buffered formalin.
Analyses of Chm-1 distribution and vascularization in
newly formed tissue
After the specimens were fixed in 10 % phosphate-
buffered formalin for 24 hours and demineralized in 5 %
formic acid for 5 days, they were dehydrated in graded al-
cohols and embedded in paraffin before preparing sections
7 μm thick. The sections were stained with hematoxylin
and eosin (H & E) and toluidine blue (TB) to evaluate the
cartilaginous matrix. Finally, Masson’s trichrome staining
(MTS) was utilized to detect the vascular structure [32].
Immunofluorescence was performed using the following
primary antibodies: anti-Col II antibody (Santa Cruz) and
anti-Chm-1 antibody (Santa Cruz). All incubations were
performed in a humidified chamber. Next, the sections
were rinsed in PBS followed by incubation with FITC-
conjugated antimouse secondary antibody (Calbiochem).
Finally, the sections were examined using a fluorescence
microscope.
The blood vessel density was quantitatively analyzed
from MTS of representative sections from each speci-
men. Vessels were identified by their luminal structure
and the presence of red blood cells stained yellow within
their boundaries. Vessels were counted from four ran-
dom fields of each section under 200× magnification as
the vessel number in each specimen. The vessel density
in each group was determined by the average number of
blood vessels from specimens (n = 4).
Statistical analysis
Results are reported as the mean ± SD, and significance
was determined using a probability value of P < 0.05.
The significance of differences between groups was
assessed using a two-way analysis of variance (ANOVA)
with Tukey’s post-hoc analysis.
Results
Different expression of Chm-1 gene in chondrocytes and
MSCs
According to the RT-PCR results, both chondrocytes
and MSCs expressed genes encoding cartilage-specific
matrix proteins, including Col II (97 base pairs (bp)) and
AGG (315 bp) (Fig. 1a). Importantly, high Chm-1 gene
(1000 bp) expression was found in chondrocytes,
whereas expression of Chm-1 gene was low in MSCs
(Fig. 1a). Furthermore, Chm-1, Col II, and AGG protein
levels were also measured using western blot. As shown in
Fig. 1b, Chm-1 protein was specifically expressed in chon-
drocytes at a level higher than that of MSCs (P < 0.01).
Immunofluorescence tests further demonstrated that the
expression of Chm-1 differed in chondrocytes and MSCs
(Fig. 1c). The result demonstrated that Chm-1 was specif-
ically expressed in chondrocytes.
Transfection of MSCs with Chm-1 gene
As shown in Fig. 1a, the Chm-1, Col II, and AGG genes
were detected by RT-PCR in the T-MSCs, whereas the
expression of Chm-1 gene was very low in the untrans-
fected MSCs. To further confirm chondrogenic pheno-
type on a protein level, Chm-1, Col II, and AGG protein
levels were also measured using western blot. As shown
in Fig. 1b, Chm-1 was specifically expressed in T-MSCs at
a level higher than that of untransfected MSCs (P < 0.01).
Meanwhile, Col II and AGG were significantly expressed
in T-MSCs at levels higher than those of MSCs (P < 0.01).
An immunofluorescence observation (Fig. 1c) indicated
that T-MSCs expressed Chm-1 and Col II, whereas no
staining could be observed in untransfected MSCs.
These findings indicated that adenovirus-mediated trans-
fection successfully generated Chm-1 gene-modified
MSCs.
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Fig. 1 (See legend on next page.)
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Construction of cell–scaffold complex
The coral scaffold is shown in Fig. 2a. Approximately
2 × 106 cells were seeded on each coral scaffold to form
a cell–scaffold complex (Each scaffold loaded with i)
chondrocytes, ii) 1:1 mixture of MSCs and chondrocytes,
iii) MSCs, and iv) T-MSCs, respectively.). According to
Fig. 2c, cell-seeding efficiency was around 75–78 %, and
cells proliferated 1.32–1.45 times on coral scaffolds
5 days after seeding in each group. There were no sig-
nificant differences among groups. Cell nuclei were
stained with Hoechst 33342 and visualized by fluores-
cence microscope. The fluorescent micrographs (Fig. 2b)
indicated that the internal structure of the coral scaffold
was porous, and that cells were evenly distributed through-
out the coral scaffolds. The results indicated that the scaf-
fold was biocompatible and able to support the initial
attachment and subsequent proliferation of MSCs in vitro.
In-vivo evaluation of the tissue-engineered cartilage
Figure 2d shows the gross appearance of specimens from
different groups 1 and 2 months after implantation.
Specimens from the chondrocyte-seeding (Fig. 2d,i) and
chondrocyte–MSC-coseeding (Fig. 2d,ii) groups ap-
peared light red. Specimens from the MSC-seeding
group (Fig. 2d,iii) were dark red, and a thin layer of soft tis-
sue and blood vessels could be observed clearly on the sur-
faces of the specimens. In contrast, specimens from the
Chm-1-transfected MSCs (Fig. 2d,iv) could be separated
easily from the adherent fibrous capsule and were light red.
H & E staining, TB staining, and MTS were performed
to examine the tissue formation and vessel density in the
scaffolds. H & E staining, TB staining, and MTS obser-
vation did not reveal obvious vascularization and bone
formation in the chondrocyte-seeding (Fig. 3a) and
chondrocyte–MSC-coseeding (Fig. 3b) groups. However,
TB staining showed mature bone formation via endo-
chondral ossification in scaffolds seeded only with MSCs
(Fig. 3c, arrow), and MTS results (Fig. 3c) revealed active
vascularization (arrow) in these specimens. By contrast, a
large amount of mature cartilage formed in the pores of
the coral scaffold, and bone formation and vascularization
were not evident in the T-MSC specimens (Fig. 3d).
Expression of the chondrogenic-specific proteins Col
II and Chm-1 was evaluated by immunohistology. As
showed in Fig. 4, Col II (green fluorescence) and Chm-1
(green fluorescence) expression were evident in the
chondrocyte-seeding (Fig. 4a) and chondrocyte–MSC-
coseeding (Fig. 4b) groups but rarely in scaffolds seeded
only with MSCs (Fig. 4c). The T-MSCs expressed abun-
dant Col II (green fluorescence) and Chm-1 (green
fluorescence), which was evenly distributed throughout
the cells (Fig. 4d).
MTS-stained vessels were observed in the specimens
after implantation for 1 and 2 months (Fig. 5). The blood
vessel density of both groups continuously increased
1–2 months after implantation. Compared with the speci-
mens seeded with MSCs (1 month 47.25 ± 3.59; 2 months
43.00 ± 4.24), the mean blood vessel densities in the chon-
drocyte–MSC-coseeding groups (1 month 4.50 ± 0.67;
2 months 12.25 ± 2.58) were significantly reduced at each
time point (P < 0.05). The mean blood vessel density in
the chondrocytes:MSCs = 1:1 group did not significantly
differ from that in the chondrocyte-seeding group
(1 month 4.25 ± 0.53; 2 months 8.00 ± 0.82; P > 0.05).
MTS indicated that the mean blood vessel density in the
T-MSC-seeding group (1 month 9.58 ± 1.85; 2 months
10.08 ± 1.64) was significantly lower than that in the
MSC-seeding group (1 month 47.25 ± 3.59; 2 months
43.00 ± 4.24) at each time point (P < 0.05).
Discussion
MSCs could undergo chondrogenic differentiation in the
presence of the appropriate growth factors and has been
considered an attractive cell source for cartilage tissue
engineering [8]. However, tissue-engineered cartilage
constructed by chondrogenic induction of MSCs exhibits
a hypertrophic phenotype and extensive calcification of
the extracellular matrix after implantation [12, 13].
Mueller and Tuan [33] reported that the combination of
TGF-β withdrawal, dexamethasone reduction, and thy-
roid hormone addition could induce hypertrophy of
chondrogenic induced MSCs, accompanied by increased
alkaline phosphatase activity, matrix mineralization, and
changes in hypertrophy markers. They concluded that
chondrogenically induced MSCs were functionally simi-
lar to growth plate chondrocytes, which underwent a
differentiation program analogous to endochondral ossi-
fication. Vascular invasion is a histological marker of
(See figure on previous page.)
Fig. 1 a RT-PCR evaluation of Chm-1, Col II, and AGG gene expression in chondrocytes, MSCs, and T-MSCs cultured in vitro. GAPDH was used as
an internal control. Intensity levels showing Chm-1, Col II, and AGG mRNA expression levels in T-MSCs and chondrocytes were significantly higher
than those of MSCs (**P < 0.01, mean ± SD, n = 4). b Western blot assay for Chm-1, Col II, and AGG expression. Chm-1, Col II, and AGG expression
were significantly upregulated in T-MSCs and chondrocytes. Analysis of band intensities indicated that Chm-1, Col II, and AGG expression levels higher
in T-MSCs and chondrocytes than the levels in MSCs (**P < 0.01, mean ± SD, n = 4). c Immunofluorescence examination showed cell transduction
efficiency 5 days after transduction. Chm-1 and Col II protein expression was evaluated by immunofluorescence examination. Data are represented as
mean ± standard deviation from four independent sets of experiments. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001 BMSC bone marrow
mesenchymal stem cell, Chm-1 Chondromodulin-1, T-BMSC Ad5-Chm-1 transfected BMSC
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endochondral ossification, and previous studies show
that the degree of vascularization significantly differs be-
tween cartilage engineered with chondrocytes and cartilage
engineered with MSCs [34], which indicate that the regula-
tion of vascular formation may differ greatly between
chondrocytes and MSCs. These drawbacks may signifi-
cantly influence the treatment of cartilage defects with
MSCs. Chm-1 is specifically expressed in the avascular
area of some mesenchymal tissues, including certain ocu-
lar tissues, cardiac valve, and cartilage [23, 35–38]. Chm-1
has been demonstrated to inhibit angiogenesis, and
many studies investigate the effects of Chm-1 and the
mechanisms by which it inhibits angiogenesis and disrupts
the vasculature [39–41].
Microfracturing of the subchondral bone plate is a fre-
quently employed approach in the clinic. The approach
could guide MSCs to migrate into the defect to improve
cartilage lesion repair [42]. Blanke et al. [25] reported that
cartilage healing from microfracturing lacked the expres-
sion of Chm-1, and was associated with excessive matrix
calcification and vascular ingrowth. And that additional
transplantation of chondrocytes could significantly pre-
vent matrix calcification and vascular ingrowth. In agree-
ment with Blanke et al.’s study, we found that MSCs
Fig. 2 a Natural coral scaffolds (8 mm in diameter and 2 mm in height). b T-MSCs and coral scaffold complex. Fluorescence microscope examination
showed the attachment of T-MSCs on the coral scaffold. Nuclei were visualized by Hoechst 33342 staining. c Cell-seeding efficacy and proliferation on coral
scaffolds (n= 4). Each scaffold was seeded with 2 × 106 cells which were i chondrocytes, ii 1:1 mixture of MSCs and chondrocytes, iii MSCs, and iv T-MSCs.
The initial 2 × 106 cells before seeding from each group acted as control. There were no significant differences among groups (P> 0.05). d Representative
macroscopic pictures of the cell–scaffold composites (i chondrocyte–coral composites, ii chondrocytes and MSCs coseeded into natural coral scaffolds in
ratio of 1:1, iii MSC–coral composites, and iv T-MSC–coral composites) removed from animals after 1 month and 2 months (Color figure online)
Chen et al. Stem Cell Research & Therapy  (2016) 7:70 Page 7 of 11
expressed cartilage-specific genes including Col II and
AGG (Fig. 1), however, unlike chondrocytes which
expressed high levels of Chm-1, the expression of Chm-1
was very low in MSCs (Fig. 1). This finding further dem-
onstrated that native MSCs are not optimized cells for
cartilage regeneration.
We then transfected MSCs with Ad5-Chm-1. Interest-
ingly, transfected MSCs not only expressed a high level of
Chm-1 but the expression of cartilage-specific genes was
also significantly upregulated (Fig. 1). Previous studies
have indicated that coculturing MSCs with chondrocytes
leads to increased chondrogenic gene expression and
ECM deposition in MSCs, and these phenotypic changes
are considered to be the result of growth factors secreted
by chondrocytes [43, 44]. According to the result of our
study, Chm-1 is also a signaling molecule that regulates
chondrogenic phenotype of MSCs.
Finally, we fabricated cartilage grafts with Chm-1-
transfected MSCs. In this experiment, we used porous
coral as a cell-seeding scaffold, which facilitates the
vascularization and ossification of engineered tissue
[45, 46]. The result showed that mature cartilage formed
in the pores of the scaffold, and bone formation was not
observed in the specimens 2 months after implantation
(Figs. 2, 3, 4). The newly formed tissue also exhibited
strong immunohistochemical staining for Chm-1. How-
ever, a large amount of bone and marrow tissue formed in
the MSC-seeding group 2 months after implantation
(Figs. 2, 3, 4). Importantly, the number of blood vessels in
the engineered graft was similar to that in the
chondrocyte-seeding group (P > 0.05) and significantly
lower than that in the MSC-seeding group (P < 0.05)
(Fig. 5). Klinger et al. [47] transfected osteochondral pro-
genitor cells with Chm-1 and subsequently transplanted
Fig. 3 Histologic analyses in chondrogenically differentiated cells and the vascularization in newly formed tissue in vivo. The specimens were transplanted
into nude mice. Appearance of specimens 1 month and 2 months post transplantation for a chondrocyte–coral composites, b chondrocytes and
MSCs coseeded into natural coral scaffolds in a ratio of 1:1, c MSC–coral composites, and d T-MSC–coral composites. The specimens were processed
for histologic staining with H & E, TB, and MTS. Red arrows indicate endochondral ossification. Black arrows indicate vascular structures. H&E hematoxylin
and eosin, MTS Masson’s trichrome staining, TB toluidine blue (Color figure online)
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cells into cartilage lesions of a joint and found that
transfected osteochondral progenitor cells maintained
chondrogenic phenotype and formed hyaline cartilage.
The avascular and hypoxia environment of the joint made
it difficult for them to obtain quantified data for the anti-
vascular effect of Chm-1. Compared with Klinger et al.,
we ectopically implanted Chm-1-transfected MSCs with
coral scaffold. Our results indicated that Chm-1 is critical
in inhibiting vascularization and maintaining the chondro-
genic phenotype of tissue-engineered cartilage from
MSCs, even in a microenvironment suitable for tissue
vascularization and ossification.
Several genes have been considered as targets to facili-
tate cartilage formation by autologous cells, including
TGF-β1, BMPs, IGF, and FGF-2 [43, 44]. The results of
the current experiment indicated that Chm-1 could not
only upregulate chondrogenic phenotype of MSCs but
could also prevent vascularization. Consequently, this
gene efficiently maintained the chondrogenic phenotype
of engineered cartilage. We conclude that Chm-1 gene-
Fig. 4 Analysis of chondrogenic protein expression for neocartilage formation in the specimens. The specimens were transplanted into nude
mice. Specimens 1 and 2 months post transplantation: a chondrocyte–coral composites; b chondrocytes and MSCs coseeded into natural coral
scaffolds in a ratio of 1:1; c MSC–coral composites; and d T-MSC–coral composites. Specimens were processed to analyze the distribution of Col II
(green) and Chm-1 (green) in cells by immunofluorescence (Color figure online)
Fig. 5 Number of vessels in the specimens 1 month and 2 months post transplantation were statistically analyzed: a chondrocyte–coral composites;
b chondrocytes and MSCs coseeded into natural coral scaffolds in a ratio of 1:1; c MSC–coral composites; and d T-MSC–coral composites. Vascular
numbers of each specimen were counted per time point as the mean ± SD. Each bar represented four specimens (*P < 0.05)
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modified MSCs may hold great potential in tissue-
engineering applications for cartilage regeneration.
Conclusions
In summary, we transfected rabbit MSCs with Ad5-Chm-
1 and seeded these cells into a natural coral tissue-
engineering scaffold to investigate the effect of exogenous
Chm-1 expression in MSCs. We report that Chm-1 inhib-
ited vascularization and maintained chondrocyte pheno-
type in vivo in Ad5-Chm-1-transfected MSCs. These
results demonstrated that Chm-1-modified MSCs may be
an optimized cell source for cartilage tissue engineering.
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